4 Insights on decentralized trials for biotechs
The COVID-19 pandemic accelerated the adoption of decentralized clinical trials (DCTs) by biopharma companies. The clinician-patient relationship will always be key to clinical trials, but decentralized aspects such as direct-to-patient shipments and telehealth are here to stay. Here are four things we have learned about DCTs that biotech companies can consider when designing a decentralized or hybrid trial.
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Blog
Including patients in DCT design
Sep 13, 2022
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Blog
Including patients in DCT design
Sep 13, 2022